Evidence and mechanisms of fat depletion in cancer

Nutrients

Volumn 6, Issue 11, 2014, Pages 5280-5297

  Ebadi, Maryam ^a   Mazurak, Vera C ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Adipose tissue; Cancer; Computed tomography; Fat mobilization

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADIPOGENESIS; ADIPOSE TISSUE; BODY MASS; CANCER GROWTH; COMPUTER ASSISTED TOMOGRAPHY; DIETARY INTAKE; EVIDENCE BASED PRACTICE; HUMAN; INFLAMMATION; INTRAABDOMINAL FAT; LIPID METABOLISM; LIPID OXIDATION; LIPOGENESIS; LIPOLYSIS; NEOPLASM; QUALITY OF LIFE; REVIEW; ADIPOCYTE; ANIMAL; BODY COMPOSITION; CACHEXIA; COMPLICATION; DISEASE MODEL; METABOLISM; PATHOLOGY; WHITE ADIPOSE TISSUE;

ANIMALIA;

ADIPOCYTES; ADIPOGENESIS; ADIPOSE TISSUE, WHITE; ANIMALS; BODY COMPOSITION; BODY MASS INDEX; CACHEXIA; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; NEOPLASMS; QUALITY OF LIFE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84938830218     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu6115280     Document Type: Review

References (74)

1. Ibrahim, M.M. Subcutaneous and visceral adipose tissue: Structural and functional differences. Obes. Rev. 2010, 11, 11–18.
2. Ntambi, J.M.; Young-Cheul, K. Adipocyte differentiation and gene expression. J. Nutr.2000, 130, 3122–3126.
3. Park, J.; Euhus, D.M.; Scherer, P.E. Paracrine and endocrine effects of adipose tissue on cancer development and progression. Endocr. Rev.2011, 32, 550–570.
4. Guilherme, A.; Virbasius, J.V.; Puri, V.; Czech, M.P. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat. Rev. Mol. Cell Biol.2008, 9, 367–377.
5. Calle, E.E.; Kaaks, R. Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms. Nat. Rev. Cancer 2004, 4, 579–591.
6. Prieto-Hontoria, P.L.; Perez-Matute, P.; Fernandez-Galilea, M.; Bustos, M.; Martinez, J.A.; Moreno-Aliaga, M.J. Role of obesity-associated dysfunctional adipose tissue in cancer: A molecular nutrition approach. Biochim. Biophys. Acta2011, 1807, 664–678.
7. Fearon, K.C. Cancer cachexia: Developing multimodal therapy for a multidimensional problem. Eur. J. Cancer 2008, 44, 1124–1132.
8. Murphy, R.A.; Wilke, M.S.; Perrine, M.; Pawlowicz, M.; Mourtzakis, M.; Lieffers, J.R.; Maneshgar, M.; Bruera, E.; Clandinin, M.T.; Baracos, V.E. et al. Loss of adipose tissue and plasma phospholipids: Relationship to survival in advanced cancer patients. Clin. Nutr.2010, 29, 482–487.
9. Fouladiun, M.; Korner, U.; Bosaeus, I.; Daneryd, P.; Hyltander, A.; Lundholm, K.G. Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care—Correlations with food intake, metabolism, exercise capacity, and hormones. Cancer2005, 103, 2189–2198.
10. Fearon, K.; Strasser, F.; Anker, S.D.; Bosaeus, I.; Bruera, E.; Fainsinger, R.L.; Jatoi, A.; Loprinzi, C.; MacDonald, N.; Mantovani, G. et al. Definition and classification of cancer cachexia: An international consensus. Lancet Oncol. 2011, 12, 489–495.
11. Bing, C.; Russell, S.; Becket, E.; Pope, M.; Tisdale, M.J.; Trayhurn, P.; Jenkins, J.R. Adipose atrophy in cancer cachexia: Morphologic and molecular analysis of adipose tissue in tumour-bearing mice. Br. J. Cancer2006, 95, 1028–1037.
12. Machado, A.P.; Costa Rosa, L.F.; Seelaender, M.C. Adipose tissue in walker 256 tumour-induced cachexia: Possible association between decreased leptin concentration and mononuclear cell infiltration. Cell Tissue Res. 2004, 318, 503–514.
13. Bertevello, P.S.; Seelaender, M.C. Heterogeneous response of adipose tissue to cancer cachexia. Braz. J. Med. Biol. Res.2001, 34, 1161–1167.
14. Batista, M.L., Jr.; Neves, R.X.; Peres, S.B.; Yamashita, A.S.; Shida, C.S.; Farmer, S.R.; Seelaender, M. Heterogeneous time-dependent response of adipose tissue during the development of cancer cachexia. J. Endocrinol.2012, 215, 363–373.
15. Agustsson, T.; Ryden, M.; Hoffstedt, J.; van Harmelen, V.; Dicker, A.; Laurencikiene, J.; Isaksson, B.; Permert, J.; Arner, P. Mechanism of increased lipolysis in cancer cachexia. Cancer Res. 2007, 67, 5531–5537.
16. Ryden, M.; Agustsson, T.; Laurencikiene, J.; Britton, T.; Sjolin, E.; Isaksson, B.; Permert, J.; Arner, P. Lipolysis—Not inflammation, cell death, or lipogenesis—Is involved in adipose tissue loss in cancer cachexia. Cancer2008, 113, 1695–1704.
17. Dahlman, I.; Mejhert, N.; Linder, K.; Agustsson, T.; Mutch, D.M.; Kulyte, A.; Isaksson, B.; Permert, J.; Petrovic, N.; Nedergaard, J. et al. Adipose tissue pathways involved in weight loss of cancer cachexia. Br. J. Cancer2010, 102, 1541–1548.
18. Mracek, T.; Stephens, N.A.; Gao, D.; Bao, Y.; Ross, J.A.; Ryden, M.; Arner, P.; Trayhurn, P.; Fearon, K.C.; Bing, C. et al. Enhanced ZAG production by subcutaneous adipose tissue is linked to weight loss in gastrointestinal cancer patients. Br. J. Cancer2011, 104, 441–447.
19. Otake, S.; Takeda, H.; Suzuki, Y.; Fukui, T.; Watanabe, S.; Ishihama, K.; Saito, T.; Togashi, H.; Nakamura, T.; Matsuzawa, Y. et al. Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: Evidence for participation of insulin resistance. Clin. Cancer Res.2005, 11, 3642–3646.
20. Hellmer, J.; Marcus, C.; Sonnenfeld, T.; Arner, P. Mechanisms for differences in lipolysis between human subcutaneous and omental fat cells. J. Clin. Endocrinol. Metab.1992, 75, 15–20.
21. Fabbro, E.D.; Bruera, E.; Demark-Wahnefried, W.; Bowling, T.; Hopkinson, J.B.; Baracos, V.E. Nutrition and the Cancer Patient; Oxford University Press: New York, NY, USA, 2010; pp. 24–28.
22. Cao, D.X.; Wu, G.H.; Yang, Z.A.; Zhang, B.; Jiang, Y.; Han, Y.S.; He, G.D.; Zhuang, Q.L.; Wang, Y.F.; Huang, Z.L. et al. Role of beta1-adrenoceptor in increased lipolysis in cancer cachexia. Cancer Sci. 2010, 101, 1639–1645.
23. Zuijdgeest-van Leeuwen, S.D.; van den Berg, J.W.; Wattimena, J.L.; van der Gaast, A.; Swart, G.R.; Wilson, J.H.; Dagnelie, P.C. Lipolysis and lipid oxidation in weight-losing cancer patients and healthy subjects. Metabolism2000, 49, 931–936.
24. Lieffers, J.R.; Mourtzakis, M.; Hall, K.D.; McCargar, L.J.; Prado, C.M.; Baracos, V.E. A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: Contributions of organ and tumor mass to whole-body energy demands. Am. J. Clin. Nutr.2009, 89, 1173–1179.
25. Shen, W.; Punyanitya, M.; Wang, Z.; Gallagher, D.; St-Onge, M.P.; Albu, J.; Heymsfield, S.B.; Heshka, S. Total body skeletal muscle and adipose tissue volumes: Estimation from a single abdominal cross-sectional image. J. Appl. Physiol. 2004, 97, 2333–2338.
26. Agustsson, T.; Wikrantz, P.; Ryden, M.; Brismar, T.; Isaksson, B. Adipose tissue volume is decreased in recently diagnosed cancer patients with cachexia. Nutrition2012, 28, 851–855.
27. Ogiwara, H.; Takahashi, S.; Kato, Y.; Uyama, I.; Takahara, T.; Kikuchi, K.; Iida, S. Diminished visceral adipose tissue in cancer cachexia. J. Surg. Oncol.1994, 57, 129–133.
28. Di Sebastiano, K.M.; Yang, L.; Zbuk, K.; Wong, R.K.; Chow, T.; Koff, D.; Moran, G.R.; Mourtzakis, M. Accelerated muscle and adipose tissue loss may predict survival in pancreatic cancer patients: The relationship with diabetes and anaemia. Br. J. Nutr. 2013, 109, 302–312.
29. Adams, J.F. The clinical and metabolic consequences of total gastrectomy. I. Morbidity, weight, and nutrition. Scand. J. Gastroenterol.1967, 2, 137–149.
30. Liedman, B.; Andersson, H.; Bosaeus, I.; Hugosson, I.; Lundell, L. Changes in body composition after gastrectomy: Results of a controlled, prospective clinical trial. World J. Surg.1997, 21, 416–421.
31. Bachmann, J.; Heiligensetzer, M.; Krakowski-Roosen, H.; Buchler, M.W.; Friess, H.; Martignoni, M.E. Cachexia worsens prognosis in patients with resectable pancreatic cancer. J. Gastrointest. Surg.2008, 12, 1193–1201.
32. Haugen, F.; Labori, K.J.; Noreng, H.J.; Buanes, T.; Iversen, P.O.; Drevon, C.A. Altered expression of genes in adipose tissues associated with reduced fat mass in patients with pancreatic cancer. Arch. Physiol. Biochem.2011, 117, 78–87.
33. Awad, S.; Tan, B.H.; Cui, H.; Bhalla, A.; Fearon, K.C.; Parsons, S.L.; Catton, J.A.; Lobo, D.N. Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer. Clin. Nutr.2012, 31, 74–77.
34. Dalal, S.; Hui, D.; Bidaut, L.; Lem, K.; del Fabbro, E.; Crane, C.; Reyes-Gibby, C.C.; Bedi, D.; Bruera, E. Relationships among body mass index, longitudinal body composition alterations, and survival in patients with locally advanced pancreatic cancer receiving chemoradiation: A pilot study. J. Pain Symptom Manag. 2012, 44, 181–191.
35. Willemse, P.P.; van der Meer, R.W.; Burggraaf, J.; van Elderen, S.G.; de Kam, M.L.; de Roos, A.; Lamb, H.J.; Osanto, S. Abdominal visceral and subcutaneous fat increase, insulin resistance and hyperlipidemia in testicular cancer patients treated with cisplatin-based chemotherapy. Acta Oncol. 2014, 53, 351–360.
36. Prado, C.M.; Sawyer, M.B.; Ghosh, S.; Lieffers, J.R.; Esfandiari, N.; Antoun, S.; Baracos, V.E. Central tenet of cancer cachexia therapy: Do patients with advanced cancer have exploitable anabolic potential? Am. J. Clin. Nutr.2013, 98, 1012–1019.
37. Tan, B.H.; Birdsell, L.A.; Martin, L.; Baracos, V.E.; Fearon, K.C. Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin. Cancer Res.2009, 15, 6973–6979.
38. Das, S.K.; Eder, S.; Schauer, S.; Diwoky, C.; Temmel, H.; Guertl, B.; Gorkiewicz, G.; Tamilarasan, K.P.; Kumari, P.; Trauner, M. et al. Adipose triglyceride lipase contributes to cancer-associated cachexia. Science2011, 333, 233–238.
39. Petruzzelli, M.; Schweiger, M.; Schreiber, R.; Campos-Olivas, R.; Tsoli, M.; Allen, J.; Swarbrick, M.; Rose-John, S.; Rincon, M.; Robertson, G. et al. A switch from white to brown fat increases energy expenditure in cancer-associated cachexia. Cell Metab. 2014, 20, 433–447.
40. Tisdale, M.J. Cachexia in cancer patients. Nat. Rev. Cancer2002, 2, 862–871.
41. Ryden, M.; Arner, P. Fat loss in cachexia—Is there a role for adipocyte lipolysis? Clin. Nutr.2007, 26, 1–6.
42. Lopez-Soriano, J.; Argiles, J.M.; Lopez-Soriano, F.J. Lipid metabolism in rats bearing the Yoshida AH-130 ascites hepatoma. Mol. Cell. Biochem.1996, 165, 17–23.
43. Lanza-Jacoby, S.; Lansey, S.C.; Miller, E.E.; Cleary, M.P. Sequential changes in the activities of lipoprotein lipase and lipogenic enzymes during tumor growth in rats. Cancer Res. 1984, 44, 5062–5067.
44. Laurencikiene, J.; Stenson, B.M.; Arvidsson Nordstrom, E.; Agustsson, T.; Langin, D.; Isaksson, B.; Permert, J.; Ryden, M.; Arner, P. Evidence for an important role of CIDEA in human cancer cachexia. Cancer Res. 2008, 68, 9247–9254.
45. Lopez-Soriano, J.; Argiles, J.M.; Lopez-Soriano, F.J. Sequential changes in lipoprotein lipase activity and lipaemia induced by the Yoshida AH-130 ascites hepatoma in rats. Cancer Lett. 1997, 116, 159–165.
46. Lopez-Soriano, J.; Argiles, J.M.; Lopez-Soriano, F.J. Marked hyperlipidaemia in rats bearing the Yoshida AH-130 ascites hepatoma. Biochem. Soc. Trans.1995, 23, 492.
47. Thompson, M.P.; Koons, J.E.; Tan, E.T.; Grigor, M.R. Modified lipoprotein lipase activities, rates of lipogenesis, and lipolysis as factors leading to lipid depletion in C57BL mice bearing the preputial gland tumor, ESR-586. Cancer Res. 1981, 41, 3228–3232.
48. Notarnicola, M.; Miccolis, A.; Tutino, V.; Lorusso, D.; Caruso, M.G. Low levels of lipogenic enzymes in peritumoral adipose tissue of colorectal cancer patients. Lipids2012, 47, 59–63.
49. Briddon, S.; Beck, S.A.; Tisdale, M.J. Changes in activity of lipoprotein lipase, plasma free fatty acids and triglycerides with weight loss in a cachexia model. Cancer Lett. 1991, 57, 49–53.
50. Bennani-Baiti, N.; Walsh, D. Animal models of the cancer anorexia-cachexia syndrome. Support. Care Cancer2011, 19, 1451–1463.
51. Bosaeus, I.; Daneryd, P.; Lundholm, K. Dietary intake, resting energy expenditure, weight loss and survival in cancer patients. J. Nutr.2002, 132, 3465–3466.
52. Cao, D.X.; Wu, G.H.; Zhang, B.; Quan, Y.J.; Wei, J.; Jin, H.; Jiang, Y.; Yang, Z.A. Resting energy expenditure and body composition in patients with newly detected cancer. Clin. Nutr.2010, 29, 72–77.
53. Johnson, G.; Salle, A.; Lorimier, G.; Laccourreye, L.; Enon, B.; Blin, V.; Jousset, Y.; Arnaud, J.P.; Malthiery, Y.; Simard, G. et al. Cancer cachexia: Measured and predicted resting energy expenditures for nutritional needs evaluation. Nutrition2008, 24, 443–450.
54. Fredrix, E.W.; Soeters, P.B.; Wouters, E.F.; Deerenberg, I.M.; von Meyenfeldt, M.F.; Saris, W.H. Effect of different tumor types on resting energy expenditure. Cancer Res. 1991, 51, 6138–6141.
55. Klein, S.; Wolfe, R.R. Whole-body lipolysis and triglyceride-fatty acid cycling in cachectic patients with esophageal cancer. J. Clin. Investig.1990, 86, 1403–1408.
56. Jeevanandam, M.; Horowitz, G.D.; Lowry, S.F.; Brennan, M.F. Cancer cachexia and the rate of whole body lipolysis in man. Metabolism1986, 35, 304–310.
57. Jaworski, K.; Sarkadi-Nagy, E.; Duncan, R.E.; Ahmadian, M.; Sul, H.S. Regulation of triglyceride metabolism. IV. Hormonal regulation of lipolysis in adipose tissue. Am. J. Physiol. Gastrointest. Liver Physiol.2007, 293, 1–4.
58. Jocken, J.W.; Blaak, E.E. Catecholamine-induced lipolysis in adipose tissue and skeletal muscle in obesity. Physiol. Behav.2008, 94, 219–230.
59. Holm, C. Molecular mechanisms regulating hormone-sensitive lipase and lipolysis. Biochem. Soc. Trans.2003, 31, 1120–1124.
60. Thompson, M.P.; Cooper, S.T.; Parry, B.R.; Tuckey, J.A. Increased expression of the mRNA for hormone-sensitive lipase in adipose tissue of cancer patients. Biochim. Biophys. Acta1993, 1180, 236–242.
61. Das, S.K.; Hoefler, G. The role of triglyceride lipases in cancer associated cachexia. Trends Mol. Med.2013, 19, 292–301.
62. Tsoli, M.; Schweiger, M.; Vanniasinghe, A.S.; Painter, A.; Zechner, R.; Clarke, S.; Robertson, G. Depletion of white adipose tissue in cancer cachexia syndrome is associated with inflammatory signaling and disrupted circadian regulation. PLoS One2014, 9, doi:10.1371/journal.pone.0092966.
63. Harms, M.; Seale, P. Brown and beige fat: Development, function and therapeutic potential. Nat. Med. 2013, 19, 1252–1263.
64. Kir, S.; White, J.P.; Kleiner, S.; Kazak, L.; Cohen, P.; Baracos, V.E.; Spiegelman, B.M. Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia. Nature2014, 513, 100–104.
65. Ishiko, O.; Nishimura, S.; Yasui, T.; Sumi, T.; Hirai, K.; Honda, K.; Ogita, S. Metabolic and morphologic characteristics of adipose tissue associated with the growth of malignant tumors. Jpn. J. Cancer Res.1999, 90, 655–659.
66. Cawthorn, W.P.; Heyd, F.; Hegyi, K.; Sethi, J.K. Tumour necrosis factor-alpha inhibits adipogenesis via a beta-catenin/TCF4 (TCF7L2)-dependent pathway. Cell Death Differ. 2007, 14, 1361–1373.
67. Bing, C.; Trayhurn, P. New insights into adipose tissue atrophy in cancer cachexia. Proc. Nutr. Soc.2009, 68, 385–392.
68. Lin, W.W.; Karin, M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J. Clin. Investig.2007, 117, 1175–1183.
69. Harman-Boehm, I.; Bluher, M.; Redel, H.; Sion-Vardy, N.; Ovadia, S.; Avinoach, E.; Shai, I.; Kloting, N.; Stumvoll, M.; Bashan, N. et al. Macrophage infiltration into omental versus subcutaneous fat across different populations: Effect of regional adiposity and the comorbidities of obesity. J. Clin. Endocrinol. Metab.2007, 92, 2240–2247.
70. Fain, J.N.; Madan, A.K.; Hiler, M.L.; Cheema, P.; Bahouth, S.W. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology2004, 145, 2273–2282.
71. Batista, M.L., Jr.; Olivan, M.; Alcantara, P.S.; Sandoval, R.; Peres, S.B.; Neves, R.X.; Silverio, R.; Maximiano, L.F.; Otoch, J.P.; Seelaender, M. et al. Adipose tissue-derived factors as potential biomarkers in cachectic cancer patients. Cytokine2013, 61, 532–539.
72. Argiles, J.M.; Alvarez, B.; Lopez-Soriano, F.J. The metabolic basis of cancer cachexia. Med. Res. Rev.1997, 17, 477–498.
73. Hosono, K.; Yamada, E.; Endo, H.; Takahashi, H.; Inamori, M.; Hippo, Y.; Nakagama, H.; Nakajima, A. Increased tumor necrosis factor receptor 1 expression in human colorectal adenomas. World J. Gastroenterol.2012, 18, 5360–5368.
74. Bing, C. Lipid mobilization in cachexia: Mechanisms and mediators. Curr. Opin. Support. Palliat. Care2011, 5, 356–360.